174 related articles for article (PubMed ID: 34435646)
1. Role of the CXCR3‑mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer.
Yuan G; Chen B; Meng Y; Lu J; Shi X; Hu A; Hu Y; Wang D
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435646
[TBL] [Abstract][Full Text] [Related]
2. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
[TBL] [Abstract][Full Text] [Related]
4. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
5. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
Bagheri V; Askari A; Arababadi MK; Kennedy D
Hum Immunol; 2014 Jun; 75(6):549-54. PubMed ID: 24530748
[TBL] [Abstract][Full Text] [Related]
6. Highly activated TRAIL
Jiang Y; Qin S; Wei X; Liu X; Guan J; Zhu H; Chang G; Chen Y; Lu H; Qian J; Wang Z; Shen M; Lin X
Immunol Lett; 2021 Apr; 232():9-19. PubMed ID: 33515618
[TBL] [Abstract][Full Text] [Related]
7. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
8. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
9. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
10. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
[TBL] [Abstract][Full Text] [Related]
11. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases.
Zhu XD; Li CL; Lang ZW; Gao GF; Tien P
World J Gastroenterol; 2004 Apr; 10(8):1141-5. PubMed ID: 15069714
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
[No Abstract] [Full Text] [Related]
13. Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.
Kinowaki K; Soejima Y; Kumagai A; Kondo F; Sano K; Fujii T; Kitagawa M; Fukusato T
Pathol Int; 2017 May; 67(5):256-263. PubMed ID: 28370778
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.
Bréchot C
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S56-61. PubMed ID: 15508104
[TBL] [Abstract][Full Text] [Related]
15. Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression.
Liu Y; Guo X; Wu L; Yang M; Li Z; Gao Y; Liu S; Zhou G; Zhao J
Oncotarget; 2016 Sep; 7(39):63856-63869. PubMed ID: 27588480
[TBL] [Abstract][Full Text] [Related]
16. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
[TBL] [Abstract][Full Text] [Related]
17. CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.
Datta D; Banerjee P; Gasser M; Waaga-Gasser AM; Pal S
J Biol Chem; 2010 Nov; 285(47):36842-8. PubMed ID: 20855888
[TBL] [Abstract][Full Text] [Related]
18. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1.
Chen Y; Zhao ZX; Huang F; Yuan XW; Deng L; Tang D
J Cell Physiol; 2019 Apr; 234(4):3555-3569. PubMed ID: 30565670
[TBL] [Abstract][Full Text] [Related]
20. Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways.
Hu N; Guo C; Dai X; Wang C; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Nov; 262():113275. PubMed ID: 32810620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
